HEXO — Hexo Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro Cap

Annual cashflow statement for Hexo, fiscal year end - July 31st, CAD millions except per share, conversion factor applied.

	R2018 July 31st	2019 July 31st	2020 July 31st	2021 July 31st	2022 July 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS/A	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-23.4	-69.6	-546	-115	-1,112
Depreciation
Amortisation
Non-Cash Items	1.63	13.2	495	54.5	951
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-7.21	-71.8	-56.5	0.431	-4.57
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities	-27.3	-125	-94.6	-43.1	-117
Capital Expenditures	-47.5	-141	-110	-32.3	-34.7
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-153	133	26.9	-419	18.4
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-200	-7.64	-83	-452	-16.3
Financing Cash Flow Items	-10.3	-3.83	-15.2	-10.4	-8.64
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	288	147	248	378	149
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	60.6	14.5	70.6	-117	15.8